Literature DB >> 31209780

Validation of Parametric Methods for [11C]UCB-J PET Imaging Using Subcortical White Matter as Reference Tissue.

Nathalie Mertens1,2, Ralph Paul Maguire3, Kim Serdons4, Brigitte Lacroix3, Joel Mercier3, David Sciberras3, Koen Van Laere4, Michel Koole4.   

Abstract

PURPOSE: The aim of this study was to evaluate different non-invasive methods for generating (R)-1-((3-([11C]methyl)pyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one) ([11C]UCB-J) parametric maps using white matter (centrum semi-ovale-SO) as reference tissue. PROCEDURES: Ten healthy volunteers (8 M/2F; age 27.6 ± 10.0 years) underwent a 90-min dynamic [11C]UCB-J positron emission tomography (PET) scan with full arterial blood sampling and metabolite analysis before and after administration of a novel chemical entity with high affinity for presynaptic synaptic vesicle glycoprotein 2A (SV2A). A simplified reference tissue model (SRTM2), multilinear reference tissue model (MRTM2), and reference Logan graphical analysis (rLGA) were used to generate binding potential maps using SO as reference tissue (BPSO). Shorter dynamic acquisitions down to 50 min were also considered. In addition, standard uptake value ratios (SUVR) relative to SO were evaluated for three post-injection intervals (SUVRSO,40-70min, SUVRSO,50-80min, and SUVRSO,60-90min respectively). Regional parametric BPSO + 1 and SUVRSO were compared with regional distribution volume ratios of a 1-tissue compartment model (1TCM DVRSO) using Spearman correlation and Bland-Altman analysis.
RESULTS: For all methods, highly significant correlations were found between regional, parametric BPSO + 1 (r = [0.63;0.96]) or SUVRSO (r = [0.90;0.91]) estimates and regional 1TCM DVRSO. For a 90-min dynamic scan, parametric SRTM2 and MRTM2 values presented similar small bias and variability (- 3.0 ± 2.9 % for baseline SRTM2) and outperformed rLGA (- 10.0 ± 5.3 % for baseline rLGA). Reducing the dynamic acquisition to 60 min had limited impact on the bias and variability of parametric SRTM2 BPSO estimates (- 1.0 ± 9.9 % for baseline SRTM2) while a higher variability (- 1.83 ± 10.8 %) for baseline MRTM2 was observed for shorter acquisition times. Both SUVRSO,60-90min and SUVRSO,50-80min showed similar small bias and variability (- 2.8 ± 4.6 % bias for baseline SUVRSO,60-90min).
CONCLUSION: SRTM2 is the preferred method for a voxelwise analysis of dynamic [11C]UCB-J PET using SO as reference tissue, while reducing the dynamic acquisition to 60 min has limited impact on [11C]UCB-J BPSO parametric maps. For a static PET protocol, both SUVRSO,60-90min and SUVRSO,50-80min images are an excellent proxy for [11C]UCB-J BPSO parametric maps.

Entities:  

Keywords:  Parametric maps; Reference tissue; Subcortical white matter; Synaptic density; [11C]UCB-J PET

Mesh:

Substances:

Year:  2020        PMID: 31209780     DOI: 10.1007/s11307-019-01387-6

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  31 in total

1.  Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging.

Authors:  Yanjun Wu; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2002-12       Impact factor: 6.200

2.  Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.

Authors:  Guomei Tang; Kathryn Gudsnuk; Sheng-Han Kuo; Marisa L Cotrina; Gorazd Rosoklija; Alexander Sosunov; Mark S Sonders; Ellen Kanter; Candace Castagna; Ai Yamamoto; Zhenyu Yue; Ottavio Arancio; Bradley S Peterson; Frances Champagne; Andrew J Dwork; James Goldman; David Sulzer
Journal:  Neuron       Date:  2014-08-21       Impact factor: 17.173

3.  Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratio.

Authors:  Zsolt Cselényi; Lars Farde
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-15       Impact factor: 6.200

4.  Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited.

Authors:  Vincent J Cunningham; Eugenii A Rabiner; Mark Slifstein; Marc Laruelle; Roger N Gunn
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-09       Impact factor: 6.200

5.  Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.

Authors:  R N Gunn; A A Lammertsma; S P Hume; V J Cunningham
Journal:  Neuroimage       Date:  1997-11       Impact factor: 6.556

6.  Synaptic loss in Alzheimer's disease and other dementias.

Authors:  J E Hamos; L J DeGennaro; D A Drachman
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

7.  Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.

Authors:  Sjoerd J Finnema; Nabeel B Nabulsi; Joël Mercier; Shu-Fei Lin; Ming-Kai Chen; David Matuskey; Jean-Dominique Gallezot; Shannan Henry; Jonas Hannestad; Yiyun Huang; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-09       Impact factor: 6.200

8.  Differential expression of synaptic vesicle protein 2 (SV2) isoforms.

Authors:  S M Bajjalieh; G D Frantz; J M Weimann; S K McConnell; R H Scheller
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

9.  Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.

Authors:  Koen Van Laere; Rawaha U Ahmad; Hendra Hudyana; Kristof Dubois; Mark E Schmidt; Sofie Celen; Guy Bormans; Michel Koole
Journal:  J Nucl Med       Date:  2013-07-10       Impact factor: 10.057

10.  Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe.

Authors:  Alexander Hammers; Richard Allom; Matthias J Koepp; Samantha L Free; Ralph Myers; Louis Lemieux; Tejal N Mitchell; David J Brooks; John S Duncan
Journal:  Hum Brain Mapp       Date:  2003-08       Impact factor: 5.038

View more
  10 in total

1.  Spatial decrease of synaptic density in amnestic mild cognitive impairment follows the tau build-up pattern.

Authors:  Greet Vanderlinden; Jenny Ceccarini; Thomas Vande Casteele; Laura Michiels; Robin Lemmens; Eric Triau; Kim Serdons; Jos Tournoy; Michel Koole; Mathieu Vandenbulcke; Koen Van Laere
Journal:  Mol Psychiatry       Date:  2022-07-06       Impact factor: 15.992

2.  Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.

Authors:  Adam P Mecca; Ming-Kai Chen; Ryan S O'Dell; Mika Naganawa; Takuya Toyonaga; Tyler A Godek; Joanna E Harris; Hugh H Bartlett; Wenzhen Zhao; Emmie R Banks; Gessica S Ni; Kelly Rogers; Jean Dominique Gallezot; Jim Ropchan; Paul R Emery; Nabeel B Nabulsi; Brent C Vander Wyk; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2021-11-20       Impact factor: 4.673

3.  Changes in synaptic density in the subacute phase after ischemic stroke: A 11C-UCB-J PET/MR study.

Authors:  Laura Michiels; Nathalie Mertens; Liselot Thijs; Ahmed Radwan; Stefan Sunaert; Mathieu Vandenbulcke; Geert Verheyden; Michel Koole; Koen Van Laere; Robin Lemmens
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-22       Impact factor: 6.960

4.  Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11 C]UCB-J.

Authors:  Adam P Mecca; Ryan S O'Dell; Emily S Sharp; Emmie R Banks; Hugh H Bartlett; Wenzhen Zhao; Sylwia Lipior; Nina G Diepenbrock; Ming-Kai Chen; Mika Naganawa; Takuya Toyonaga; Nabeel B Nabulsi; Brent C Vander Wyk; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Alzheimers Dement       Date:  2022-02-17       Impact factor: 16.655

Review 5.  Synaptic Vesicle Glycoprotein 2A: Features and Functions.

Authors:  Rachele Rossi; Shokouh Arjmand; Simone Larsen Bærentzen; Albert Gjedde; Anne M Landau
Journal:  Front Neurosci       Date:  2022-04-28       Impact factor: 5.152

6.  In vivo synaptic density relates to glucose metabolism at rest in healthy subjects, but is strongly modulated by regional differences.

Authors:  June van Aalst; Jenny Ceccarini; Stefan Sunaert; Patrick Dupont; Michel Koole; Koen Van Laere
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

7.  Kinetics and 28-day test-retest repeatability and reproducibility of [11C]UCB-J PET brain imaging.

Authors:  Hayel Tuncel; Ronald Boellaard; Emma M Coomans; Erik Fj de Vries; Andor Wjm Glaudemans; Paula Kopschina Feltes; David V García; Sander Cj Verfaillie; Emma E Wolters; Steven P Sweeney; J Michael Ryan; Magnus Ivarsson; Berkley A Lynch; Patrick Schober; Philip Scheltens; Robert C Schuit; Albert D Windhorst; Peter P De Deyn; Bart Nm van Berckel; Sandeep Sv Golla
Journal:  J Cereb Blood Flow Metab       Date:  2020-10-08       Impact factor: 6.200

8.  In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.

Authors:  Adam P Mecca; Ming-Kai Chen; Ryan S O'Dell; Mika Naganawa; Takuya Toyonaga; Tyler A Godek; Joanna E Harris; Hugh H Bartlett; Wenzhen Zhao; Nabeel B Nabulsi; Brent C Vander Wyk; Pradeep Varma; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  Alzheimers Dement       Date:  2020-05-13       Impact factor: 21.566

9.  Human biodistribution and dosimetry of [11C]-UCB-J, a PET radiotracer for imaging synaptic density.

Authors:  Koen Van Laere; Michel Koole; Christopher Cawthorne; Paul Maguire; Joel Mercier; David Sciberras; Kim Serdons; Guy Bormans; Jan de Hoon
Journal:  EJNMMI Phys       Date:  2021-04-23

10.  Validation and test-retest repeatability performance of parametric methods for [11C]UCB-J PET.

Authors:  Hayel Tuncel; Ronald Boellaard; Emma M Coomans; Marijke den Hollander-Meeuwsen; Erik F J de Vries; Andor W J M Glaudemans; Paula Kopschina Feltes; David Vállez García; Sander C J Verfaillie; Emma E Wolters; Steven P Sweeney; J Michael Ryan; Magnus Ivarsson; Berkley A Lynch; Patrick Schober; Philip Scheltens; Robert C Schuit; Albert D Windhorst; Peter P De Deyn; Bart N M van Berckel; Sandeep S V Golla
Journal:  EJNMMI Res       Date:  2022-01-24       Impact factor: 3.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.